Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9377538 | Biological Psychiatry | 2005 | 7 Pages |
Abstract
These data support the clinical observation that low-dose L-dopa might improve the effect of typical APDs in schizophrenia and indicate that increased prefrontal DA output per se enhances the antipsychotic effect of typical APDs.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Amani Eltayb, Marie-Louise G. Wadenberg, Torgny H. Svensson,